Loss of FHIT expression in acute lymphoblastic leukemia.
暂无分享,去创建一个
C. Hallas | C. Croce | K. Huebner | M. Albitar | M. Keating | J. Letofsky
[1] M. Tschan,et al. Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia , 1999, Oncogene.
[2] M. Rugge,et al. Loss of FHIT expression in gastric carcinoma. , 1998, Cancer research.
[3] L. Cannizzaro,et al. FHIT gene transcript alterations occur frequently in myeloproliferative and myelodysplastic diseases , 1998, Cytogenetic and Genome Research.
[4] R. Aguiar,et al. Aberrant transcripts of the FHIT gene are expressed in normal and leukaemic haemopoietic cells. , 1998, British Journal of Cancer.
[5] Y. Pekarsky,et al. Absence or reduction of Fhit expression in most clear cell renal carcinomas. , 1998, Cancer research.
[6] D. Christiani,et al. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. , 1998, Cancer research.
[7] B. Simon,et al. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines. , 1998, Cancer research.
[8] Jan-Gowth Chang,et al. Analysis of FHIT transcripts in cervical and endometrial cancers , 1998, International journal of cancer.
[9] O. Cussenot,et al. Molecular analysis of the FHIT gene in human prostate cancer , 1998, Oncogene.
[10] P. H. Chen,et al. Aberrant FHIT transcripts in hepatocellular carcinomas. , 1998, British Journal of Cancer.
[11] C. Shen,et al. HPV‐associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA , 1998, International journal of cancer.
[12] L. D. Barnes,et al. Replacement of Fhit in cancer cells suppresses tumorigenicity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[13] C. Croce,et al. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities. , 1997, Cancer research.
[14] T. Goodrow,et al. The FHIT gene product is highly expressed in the cytoplasm of renal tubular epithelium and is down-regulated in kidney cancers. , 1997, The American journal of pathology.
[15] J. Chang,et al. Aberrant FHIT transcripts in acute myeloid leukaemia , 1997, British journal of haematology.
[16] Kathleen R. Cho,et al. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. , 1997, Cancer research.
[17] Stanley N Cohen,et al. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours , 1997, Oncogene.
[18] D. Beer,et al. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas , 1997, Oncogene.
[19] F. Mitelman,et al. Variable FHIT transcripts in non‐neoplastic tissues , 1997 .
[20] S. Naylor,et al. Normal FHIT transcripts in renal cell cancer‐ and lung cancer‐derived cell lines, including a cell line with a homozygous deletion in the FRA3B region , 1997, Genes, chromosomes & cancer.
[21] G. Giaccone,et al. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. , 1997, Cancer research.
[22] M. Birrer,et al. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. , 1997, Cancer research.
[23] K. Miyagawa,et al. Decreased or Altered Expression of the FHIT Gene in Human Leukemias , 1997, Stem cells.
[24] C. Croce,et al. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. , 1997, Cancer research.
[25] C. Croce,et al. Structure and expression of the human FHIT gene in normal and tumor cells. , 1997, Cancer research.
[26] H. Klinger,et al. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. , 1997, Human molecular genetics.
[27] L. D. Barnes,et al. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase. , 1996, Biochemistry.
[28] C. Croce,et al. FHIT gene alterations in head and neck squamous cell carcinomas. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[29] C. Croce,et al. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. , 1996, Cancer research.
[30] C. Croce,et al. The FHIT Gene at 3p14.2 Is Abnormal in Lung Cancer , 1996, Cell.
[31] M. Rugge,et al. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. , 1996, Cancer research.
[32] C. Croce,et al. The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.
[33] T. Glover,et al. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. , 1996, Human molecular genetics.
[34] G. Huez,et al. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. , 1995, Blood.
[35] D. Jong,et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. , 1995, Blood.
[36] S. Knuutila,et al. Cloning and characterization of the human t(3;6)(p14;p11) translocation breakpoint associated with hematologic malignancies. , 1993, Cancer genetics and cytogenetics.
[37] K. Tanaka,et al. Loss of heterozygosity at D3S2 locus of short arm of chromosome 3 in chronic myelogenous leukemia. , 1992, Cancer genetics and cytogenetics.
[38] C. Croce,et al. FHIT in human cancer. , 1998, Advances in cancer research.